Scientists reveal why Valium can be addictive
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists on Wednesday said they had figured out why people get hooked on a class of prescription drugs that includes Valium, along with other antidepressants, muscle relaxants and sleeping pills.
The findings, reported in the British science journal Nature, open a path to developing new treatments that can ease symptoms without causing dependence, the researchers hope.
Opium, heroin and cannabinoids are addictive because they activate a neural circuit that boosts levels of a reward-giving brain chemical called dopamine.
The molecular pathway they use to unleash the dopamine is well known.
Benzodiazepines - which include Valium, Xanax, Librium, Ambien and other well-known drugs - likewise stimulate the dopamine system, but until now how they did this was unclear.
In a series of experiments on mice, a team led by Christian Luscher at the University of Geneva say they have solved the mystery.
Benzodiazepines switch on a intermediary neurotransmitter known as gamma-aminobutyric acid, or GABA, increase dopamine levels, resulting in the signature craving of addiction, they found.
The pathway that has been uncovered does not have an effect on benzodiazepines' therapeutic effects.
As a result, it should be possible to design new drugs that deliver the same benefits but without inducing addiction, said the researchers.
The work "is a landmark for the field," noted Arthur Riegel and Peter Kalivas of the Medical University of South Carolina in Charleston.
"These authors are the first to identify a molecular mechanism contributing to benzodiazepine abuse," the pair wrote in a commentary, also in Nature.
mh/ri/ach
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments